BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

NeuroMetrix

NeuroMetrix, Inc. was founded in June 1996 as a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. The Company’s mission is to: Create value for our customers by developing innovative neurological diagnostic and therapeutic solutions that maximize quality of care and economic outcomes Produce a superior return on investment for our shareholders Provide our employees with an opportunity for growth so that they may realize their professional potential The Company is accomplishing these goals by utilizing its proprietary technology platform and its core competency in biomedical engineering, neurophysiology and information technology to develop and commercialize a line of novel neurological diagnostic tests and therapeutic interventions. The key elements of the Company's proprietary technology are: Advanced biosensors that communicate bioelectrical signals between physiological tissue, such as peripheral nerves, and electronic instruments. Sophisticated bioelectronic instruments interface with the biosensors and enable diagnostic and therapeutic procedures. Biomedical signal processing, automation and analysis algorithms. Informatics and decision support software that maximizes clinical utility. Markets At the present time, the Company is focused on the tremendous unmet clinical need in point-of-service neurodiagnostic testing created by tens of millions of annual patient visits related to nerve pathology, as well as in very high rates of nerve related repetitive stress disorders in many industries. The Company’s flagship product, the NC-stat® is a nerve conduction-testing platform that has been on the market since 2000. The NC-stat is used by orthopedic surgeons, neurosurgeons, neurologists, physiatrists, rheumatologists, internal medicine physicians, occupational health physicians, pain medicine physicians, general practitioners, and others, to assist in the diagnosis or exclusion of peripheral nerve disorders.


Contact Details:
62 Fourth Ave
Waltham
MA
02451
United States of America
Tel:781-890-9989
Fax:
Email:info@neurometrix.com
WWW:

www.neurometrix.com




Loading...

Recent Publications by NeuroMetrix:

Detection and classification of motor nerve late-wave activity.
The health of peripheral nerves is commonly assessed using nerve...
15th March, 2008
Neurometrix, Inc., 62 Fourth St, Waltham MA 02451, USA. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1441-4.
DOI Direct Link
F-wave decomposition for time of arrival profile estimation.
F-waves are distally recorded muscle responses that result from...
14th March, 2008
Neurometrix Inc., 62 4th Ave., Waltham, MA 02451, USA. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:698-700.
DOI Direct Link
Automated removal of stimulus artifact in nerve conduction studies.
An algorithm for automated removal of stimulus artifact has been developed...
1st March, 2008
Neurometrix Inc., Conf Proc IEEE Eng Med Biol Soc. 2006;1:6360-3.
DOI Direct Link
Peroneal F-wave characteristics under submaximal stimulation.
PURPOSE: F-wave studies are valuable tools in clinical neurophysiology....
21st February, 2008
NeuroMetrix Neurol Neurophysiol Neurosci. 2006 Jan 7:1.
Repeatability of nerve conduction measurements using automation.
OBJECTIVE: To quantify nerve conduction study (NCS) reproducibility...
19th August, 2007
NeuroMetrix, Inc, 62 Fourth Avenue, Waltham, MA 02451, USA. J Clin Monit Comput. 2006 Dec;20(6):405-10. Epub 2006 Sep 14.
DOI Direct Link

View more NeuroMetrix research publications.

BioNews Results for NeuroMetrix:

NeuroMetrix Rises in Premarket on FDA Clearance of Electrodes
FDA News:  Oct 3 2008 3:49PM Matching: neurometrix
NeuroMetrix Receives FDA 510(k) Clearance for UNIVERSAL(TM) Electrodes used in the Performance of Nerve Conduc
DiGiTAL50:  Oct 2 2008 7:28PM Matching: neurometrix
Focus on the World Diabetes Diagnostics Market
Street Insider:  Oct 1 2008 3:25PM Matching: neurometrix

NeuroMetrix Patents:

US Patent No.Title
6936012 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals
5976094 Apparatus and methods for assessment of neuromuscular function
6132386 Methods for the assessment of neuromuscular function by F-wave latency
6132387 Neuromuscular electrode
6146335 Apparatus for methods for the assessment of neuromuscular function of the lower extremity

View more NeuroMetrix patents.

NeuroMetrix (NURO) Financial information Links from Barchart

NURO Quote from from Barchart.com
NURO Chart from from Barchart.com
NURO Profile from from Barchart.com
NURO Opinion from from Barchart.com

View more NeuroMetrix finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 127 times since April 2007, the link to the organisation's website has been followed 26 times

Recent Search Terms used to find this page: NEUROMETRIX.COM | Neurometrix research | neurometrix.com | neurometrix.com | neurometrix f-wave | NeuroMetrix acquired EyeTel Imaging in late 2007. | .

Search for more companies in Waltham

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for NeuroMetrix
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.